Other languages Avivagen Inc.

Equities

VIV

CA05382F2026

Delayed Toronto S.E. Other stock markets 09:30:00 2024-03-05 EST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2023	Avivagen Inc. Announces New 500 Kg Order for OxC-beta	CI
2023	Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avivagen Inc. Announces New 500 Kg Order for OxC-beta	23-10-17
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-28
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product	23-07-24
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-06
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer	23-05-25
Avivagen Announces Review of Strategic Alternatives	23-05-17
Avivagen Inc. Announces Board Changes	23-04-19
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern	23-03-17
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-03-16
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-02-21
Avivagen Inc. Auditor Raises 'Going Concern' Doubt	23-02-20
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-16
Avivagen anuncia su nuevo cliente de productos lácteos en México	22-08-23
Avivagen Reports New Customer in Mexico; Up 8.6%	22-08-19
Avivagen Inc. Secures New Customer in the Mexican Dairy Industry	22-08-19
Avivagen Inc. Announces Receipt of Repeat Order from Asian Customer	22-08-11
Avivagen Inc. Secures Order for OxC-beta from AB Vista	22-08-03
Avivagen Inc. Announces Sales of Companion Animal Product and 6,000 pouches order through new and existing customers in Taiwan and Mexico	22-07-29
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-15
Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene	22-06-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Avivagen Inc.

Equities

VIV

CA05382F2026

Other languages

Filters